Novel treatment strategy of type 2 diabetes focused on beta cell mass
Project/Area Number |
21890213
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Metabolomics
|
Research Institution | Yokohama City University |
Principal Investigator |
NAKAMURA Akinobu Yokohama City University, 附属病院, 助教 (70552420)
|
Project Period (FY) |
2009 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Fiscal Year 2010: ¥1,235,000 (Direct Cost: ¥950,000、Indirect Cost: ¥285,000)
Fiscal Year 2009: ¥1,365,000 (Direct Cost: ¥1,050,000、Indirect Cost: ¥315,000)
|
Keywords | 膵β細胞量 / グルコキナーゼ / 妊娠 |
Research Abstract |
We investigated the effect of glucokinase activator (GKA) on beta cell function and proliferation. Glucokinase activation by GKA increased expression levels of IRS-2 and cell cycle signaling molecules. GKA was able to stimulate beta cell proliferation independently of insulin stimulation and stimulate beta cell function independently of IRS-2. Also, our results raise the possibility that GKA do not work well under excessive oxidative stress in beta cells.
|
Report
(3 results)
Research Products
(17 results)